Why Most Investors Never Capture the Returns They’re Chasing

At Itus Capital, we study how wealth is actually built — not how it looks in a bull market.

Every few years, a new narrative takes hold. Search Google for “best multibagger stocks” in India and you’ll see the trend line — interest surged 20× in the last decade, peaking precisely when markets were at their richest. Search for “best performing small cap MFs” and you’ll see the same pattern: spikes at every market high, and again after every crash.

Investors are not searching for process. They are searching for outcomes — and always at the wrong point in the cycle.

This post examines four narratives that shape how most investors think about equity investing, and what the full-cycle data actually says.

The Four Narratives — and Why They’re Incomplete

Small Cap = Alpha. True, but conditionally. The alpha is real and the data confirms it — but it comes with drawdowns that most investors cannot psychologically or financially survive.

Concentration = Conviction. Partially true. Focused portfolios can generate superior returns, but only when the underlying businesses are high quality and the entry timing is not at peak cycle valuations.

Diversification = Mediocrity. False. As we will show with Nippon India Small Cap, holding 247 stocks across 20+ sectors while generating 23% CAGR since inception is not mediocrity. It is a structurally intelligent way to capture an asset class.

Buy & Hold = The Answer. True in theory. Devastatingly false in practice, for reasons the data makes painfully clear.

What Full-Cycle Evidence Actually Shows

Itus Capital studied two complete market cycles across India’s listed small and micro-cap universe.

Cycle 1: January 2014 – February 2020 (874 companies)

During the bull phase (Jan 2014 – Jan 2018), small and micro-caps delivered extraordinary returns. 56% of companies delivered 3x or more. Only 26% of large caps (Nifty 250) matched that threshold. The alpha case looked undeniable.

Then the bear arrived. From January 2018 to February 2020 — a period most investors barely remember as a distinct bear market — the small/micro universe fell 58%. The Nifty Top 250 fell only 26%.

By the full cycle, the 3x+ edge had compressed from 56 percentage points to just 26. More than half the alpha had been eroded.

Cycle 2: February 2020 – March 2026 (1,322 companies)

The bull phase of Cycle 2 was even more spectacular. 62% of small/micro companies delivered 3x or more in the Feb 2020 to Dec 2024 run — the strongest reading in recent memory.

The current bear phase (Dec 2024 onwards) has already taken the small/micro universe down 40%, against only 15% for the Top 250. The full-cycle 3x+ edge has compressed from 62 points to 41 — and the bear is not finished.

The conclusion is not that small caps are a bad investment. It is that the alpha is time-sensitive. The multi-bagger advantage exists — but it is available to you only if you enter at the right point in the cycle and, critically, do not exit during the bear.

The Alpha Is Real. So Is the Cost.

Across our shortlisted small cap funds (7 funds), large & mid cap funds (6 funds), and flexi cap funds (5 funds), the return data is clear:

• At 3 years: Small caps average 24% CAGR — 950 basis points above Nifty 50
• At 5 years: Small caps average 22.6% CAGR — 550 basis points above
• At 8 years: The alpha compresses to near-zero. Cycle entry timing begins to dominate

The price for that alpha? A peak-to-trough drawdown of 57% during the 2018–20 bear. Small caps fell to ₹43 for every ₹100 invested at the peak. The Nifty 100 fell to ₹78.

The verdict: If you can hold through −40% to −57% drawdowns, small cap is the superior compounder. If you cannot — and most investors genuinely cannot, regardless of what they tell themselves in a bull market — Large & Mid Cap delivers 80% of the alpha at significantly shallower drawdowns and faster recovery times.

The Hidden Cost No One Talks About

Since 2008, the small cap index has experienced four significant bear phases:

• 2008 GFC: −65% drawdown. ₹1 Crore became ₹35 Lakhs. Recovery: 3–4 years.
• 2011 correction: −30% drawdown.
• 2018–2020 extended bear: −55% peak-to-trough (IL&FS crisis into NBFC stress into the COVID trough). ₹1 Crore became ₹45 Lakhs. Recovery: 20 months from trough.
• 2024–25 ongoing correction: −40% (broader small/micro universe) and counting.

The question that should sit at the centre of every portfolio conversation is simple: Which client actually stayed invested through all four of these?

The honest answer, supported by data, is: very few.

The Behavioral Reality

The data on investor behaviour is more damning than any bear market.

India’s average equity mutual fund holding period is 2.5 years. Nearly half of all equity assets are held for less than 24 months. The theoretical argument for small cap alpha requires 5–8 year holding periods minimum.

The US average holding period is 4.79 years — almost double India’s — and yet US investors still chronically underperform their own funds (source: DALBAR QAIB 2025).

The India behavior gap is 530 basis points per year. Axis Mutual Fund’s 20-year study (2003–2022) found that while equity funds delivered 19.1% CAGR, investors in those same funds earned only 13.8% — a 530bps annual shortfall from timing errors alone.

Here is the core irony: Small cap’s 5-year alpha over Nifty 50 is approximately 550 basis points. India’s behavioral gap is 530 basis points. The entire alpha advantage is, in practice, erased by the tendency to buy after rallies and sell during corrections.

The funds delivered. The investors did not capture it.

Reframing the Question

The right question is not “Small Cap or Large Cap?”

It is: Can value be found beyond market cap labels?

Market cap alone does not determine business quality, longevity, capital efficiency, or compounding ability. A ₹500 Crore company with 28% ROCE, zero debt, and genuine pricing power is structurally superior to a ₹5,000 Crore company with 9% ROCE and a leveraged balance sheet — regardless of what category it sits in.

Every sector goes through cycles. The businesses that compound through cycles are the ones worth owning. The data on sector rotation makes this explicit:

• IT Services: generated 48% CAGR in 2009–13, then turned negative in 2024–25
• Defence: steadily accelerated from 20% in 2009–13 to 51% in 2024–25
• Chemicals: surged 90% in 2021, then fell for three consecutive years

Yesterday’s winning sector becomes tomorrow’s laggard with remarkable consistency. Passive allocation to last cycle’s leaders locks you into exactly the wrong position.

What Quality Compounding Actually Looks Like

Consider the period from February 2020 to December 2024 — small cap’s best bull run in a decade.

The small cap fund generated ₹40 Lakhs more. The quality index generated a Sharpe ratio 6.5× higher. The difference in wealth outcome is ₹40 Lakhs. The difference in behavioral survivability — the probability that a real investor stayed invested through the journey — is far larger than that number suggests.

The best portfolio is not the one with the highest peak return. It is the one the investor actually stays in.

Diversification Is Not Mediocrity

Nippon India Small Cap Fund is the most data-rich proof of this argument.

The fund holds 247 stocks across 20+ sectors. No single stock exceeds 2.5% of the portfolio. 67 stocks have been held continuously for 3+ years. The category average is 70–80 stocks. Nippon holds 3–4× more.

This is not unfocused investing. The fund has delivered 23% CAGR since inception (2010), with a ₹10,000 investment growing to ₹1.81 Lakhs — against a benchmark return of ₹68,774 and a category average of ₹1.05 Lakhs.

Within Capital Goods alone, the fund holds 33 stocks — Apar Industries, Thermax, Suzlon, and 30 more. These companies can and do move independently of each other in the same year. Within Healthcare, 28 stocks. Within Auto & Ancillaries, 22 stocks.

The structure ensures no single stock, sector, or thesis can determine the portfolio’s outcome. When the 2024–25 correction arrived and Capital Goods fell 15% and Auto fell 18%, Healthcare returned +8% and IT bounced +12%. The fund fell just 4.7% — a fraction of its weakest sectors. That gap is diversification working.

What We Believe

Three things, drawn from everything the data shows.

01 — Move beyond market cap labels. Quality is not a function of size. It is a function of business economics — ROIC trajectory, earnings quality, governance, pricing power, balance sheet discipline. A quality business at a reasonable valuation will compound regardless of whether it is classified as small cap, mid cap, or large cap.

02 — Think across cycles and sectors. Every sector has a cycle. The question is not which sector is performing now. It is which businesses have the quality to survive the down cycle and emerge stronger. This requires a cycle-aware investment lens, not a return-chasing one.

03 — Build portfolios clients can hold. The behavioral gap data is unambiguous. Portfolios with shallower drawdowns and faster recoveries are held for longer. Portfolios held for longer capture more of the compounding. The best strategy, for most investors, is not the strategy with the highest theoretical return — it is the one they can emotionally and financially survive through a full cycle.

As the evidence makes clear: compounding only works if the investor survives the cycle.

Itus Capital Advisors is a SEBI-registered portfolio manager based in Chennai. This post is for educational purposes and does not constitute investment advice.

Data sources: AMFI Annual Reports, Value Research, NSE Indices, DALBAR QAIB 2025, Equitymaster, Morningstar. All fund returns are CAGR, as of April 2026.

The performance-related information provided in this newsletter/blog is not verified by SEBI. The content is intended solely for internal circulation and general informational purposes. It does not constitute investment advice or any form of financial recommendation.

The research information shared herein may contain inaccuracies or typographical errors. All liability for actions taken or not taken based on the content of this newsletter/blog is expressly disclaimed.

No reader, user, or browser of this Newsletter / blog should act or refrain from acting based on any information in this newsletter/blog without seeking independent financial advice. Use of, and access to, this publication or any links or resources provided within do not establish a portfolio manager-client relationship between the reader, user, or browser and the authors, contributors or Itus Capital.